Premium
P4‐184: Profile of selective ORL1 antagonist demonstrates mechanism safe to target for symptomatic treatment in Alzheimer's Disease
Author(s) -
Duplantier Allen,
Iyer Rathna,
Pettersen Betty,
Roof Robin,
Cianfrogna Julie,
Leung Louis,
Brodney Michael,
McDowell Laura,
Barricklow Jason,
Can Keri,
Chang Cheng,
Leurent Claire,
Prior Faith,
Taylor Christine,
Wisialowski Todd
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.2207
Subject(s) - pharmacology , euphoriant , nociceptin receptor , antagonist , medicine , tolerability , antagonism , sedation , adverse effect , receptor , opioid , opioid peptide , psychiatry